Abstract
Oncolytic viruses are viruses that have been genetically modified to specifically infect and kill cancer cells. They have significant potential in the field of cancer therapy because they possess many advantages over traditional treatments, such as selective killing of tumor cells, increasing the immunogenicity of tumor cells, and avoiding the side effects of chemotherapy and radiotherapy. Currently, several oncolytic viruses have shown good safety and efficacy in clinical trials. More combination therapy strategies are being explored, and it is expected that oncolytic viruses will be more widely used in cancer treatment in the future.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
